Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

p57 is required for quiescence and maintenance of adult hematopoietic stem cells.

Cell stem cell | Sep 2, 2011

http://www.ncbi.nlm.nih.gov/pubmed/21885021

Quiescence is required for the maintenance of hematopoietic stem cells (HSCs). Members of the Cip/Kip family of cyclin-dependent kinase (CDK) inhibitors (p21, p27, p57) have been implicated in HSC quiescence, but loss of p21 or p27 in mice affects HSC quiescence or functionality only under conditions of stress. Although p57 is the most abundant family member in quiescent HSCs, its role has remained uncharacterized. Here we show a severe defect in the self-renewal capacity of p57-deficient HSCs and a reduction of the proportion of the cells in G(0) phase. Additional ablation of p21 in a p57-null background resulted in a further decrease in the colony-forming activity of HSCs. Moreover, the HSC abnormalities of p57-deficient mice were corrected by knocking in the p27 gene at the p57 locus. Our results therefore suggest that, among Cip/Kip family CDK inhibitors, p57 plays a predominant role in the quiescence and maintenance of adult HSCs.

Pubmed ID: 21885021 RIS Download

Mesh terms: Adult Stem Cells | Animals | Cell Aging | Cell Growth Processes | Cell Survival | Colony-Forming Units Assay | Cyclin-Dependent Kinase Inhibitor p21 | Cyclin-Dependent Kinase Inhibitor p57 | Gene Knock-In Techniques | Hematopoiesis | Hematopoietic Stem Cells | Mice | Mice, Inbred C57BL | Mice, Knockout | Proliferating Cell Nuclear Antigen

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Mouse Genome Informatics (Data, Gene Annotation)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.